<DOC>
	<DOCNO>NCT00840840</DOCNO>
	<brief_summary>The purpose study assess bioequivalence Amoxicillin/Clavulanate Potassium Oral Suspension 600/42.9 mg/5 mL Augmentin ES-600 Oral Suspension , 600/42.9 mg/5 mL healthy , male female subject , fed condition .</brief_summary>
	<brief_title>600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fed Conditions</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Healthy , nonsmoking male nonpregnant , nonlactating female subject , 18 year age . Body weight within ±15 % appropriate weight range publish 1993 Metropolitan Life Insurance Company , Statistical Bureau bodymass index ( BMI ) less 30 . Negative : HIV Hepatitis B C Urine drug abuse test ( marijuana , amphetamine , barbiturate , cocaine , opiates , benzodiazepine methadone ) . Cotinine ( urine test ) Breath alcohol ( Breathalyzer ) HCG ( female ) No significant diseases clinically significant abnormal laboratory value . No clinically significant finding physical examination . No clinically significant finding vital sign measurement 12lead electrocardiogram ( ECG ) . Informed nature study give write consent prior receive study medication . Female subject : surgically steril , postmenopausal practice recognize safe method contraception ( abstention , oral implanted contraceptive , intrauterine device consistent condom plus spermicide use ) . Known history presence disease condition might compromise follow body system : immunologic , endocrine , renal , cardiovascular , respiratory , hematologic , gastrointestinal , neurologic , hepatic , psychiatric dermatologic More specifically : history presence significant : sensitivity multiple allergen , diarrhea , stomach intestinal disease , mononucleosis , renal hepatic dysfunction asthma . Known suspected carcinoma . Known history presence : Hypersensitivity idiosyncratic reaction amoxicillin , clavulanic acid , penicillin , cephalosporins and/or βlactamase inhibitor . Clavulinassociated jaundice/hepatic dysfunction . Alcoholism within last 12 month . Drug dependence and/or substance abuse . Use tobacco nicotinecontaining product , within last 12 month . On special diet within 4 week prior drug administration ( i.e . deliberate change diet reason ) . Participation another clinical trial receive investigational product previous 30 day prior drug administration . Donation 250 mK blood previous 30 day , 251500 mKL previous 45 day , 501750 mL previous 60 day 750 mL previous 90 day prior study start . Requirement medication , ( prescription and/or overthecounter ) dietary supplement routine basis , exception occasional use acetaminophen oral implant contraceptive . Difficulty fast consume standard prescribe meal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>